Presentation is loading. Please wait.

Presentation is loading. Please wait.

Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?  Luis.

Published byJudith Hildur Olsen Modified over 5 years ago

Similar presentations

Presentation on theme: "Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?  Luis."— Presentation transcript:

1 Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?  Luis T. Mercé, M.D., Ph.D., María J. Barco, M.D., Ph.D., Santiago Bau, M.D., Ph.D., Juan Troyano, M.D., Ph.D.  Fertility and Sterility  Volume 89, Issue 1, Pages (January 2008) DOI: /j.fertnstert Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Three dimensional images by VOCAL software: (A) endometrial volume and (B) endometrial vascular network on the day of human chorionic gonadotropin administration. Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Download ppt "Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?  Luis."

Similar presentations

Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication.

Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication.
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T

Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M

Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 

Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 
Three-parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases  Paula Amato, M.D., Masahito Tachibana, M.D.,

Three-parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases  Paula Amato, M.D., Masahito Tachibana, M.D.,
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 

Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc

Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.
Michael M. Alper, M.D.  Fertility and Sterility 

Michael M. Alper, M.D.  Fertility and Sterility 
Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro.

Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Effect of a very-low-calorie diet on in vitro fertilization outcomes

Effect of a very-low-calorie diet on in vitro fertilization outcomes
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial 

Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial 
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Live birth of twins derived from zona-free oocytes

Live birth of twins derived from zona-free oocytes
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

Similar presentations

Ads by Google